{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T05:14:39Z","timestamp":1771046079308,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015809","name":"Health Medical Collaborative Innovation Program of Guangzhou","doi-asserted-by":"publisher","award":["201803040003"],"award-info":[{"award-number":["201803040003"]}],"id":[{"id":"10.13039\/501100015809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81930072"],"award-info":[{"award-number":["81930072"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015956","name":"Special Project for Research and Development in Key areas of Guangdong Province","doi-asserted-by":"publisher","award":["2019B020230002"],"award-info":[{"award-number":["2019B020230002"]}],"id":[{"id":"10.13039\/501100015956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People&apos;s Republic of China","doi-asserted-by":"publisher","award":["IRT_17R110"],"award-info":[{"award-number":["IRT_17R110"]}],"id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2017A030312003"],"award-info":[{"award-number":["2017A030312003"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013314","name":"Higher Education Discipline Innovation Project","doi-asserted-by":"publisher","award":["B14035"],"award-info":[{"award-number":["B14035"]}],"id":[{"id":"10.13039\/501100013314","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013313","name":"Overseas Expertise Introduction Project for Discipline Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.radonc.2020.08.019","type":"journal-article","created":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T00:28:57Z","timestamp":1598660937000},"page":"306-313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Association between outcome disparities and pragmatic features related to clinical trial and real-world settings in nasopharyngeal carcinoma: A population-based retrospective cohort study, 2006\u20132016"],"prefix":"10.1016","volume":"151","author":[{"given":"Cheng","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7605-3609","authenticated-orcid":false,"given":"Wen-Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si-Qi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Long","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai-Hua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2020.08.019_b0005","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0021-9681(67)90041-0","article-title":"Explanatory and pragmatic attitudes in therapeutical trials","volume":"20","author":"Schwartz","year":"1967","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.radonc.2020.08.019_b0010","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMra1510059","article-title":"Pragmatic trials","volume":"375","author":"Ford","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2020.08.019_b0015","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMsb1609216","article-title":"Real-world evidence - What is it and what can it tell us?","volume":"375","author":"Sherman","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2020.08.019_b0020","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.2217\/fon-2018-0539","article-title":"Comparison of outcomes of radiotherapy-treated localized prostate cancer patients within a clinical trial setting versus real-life setting","volume":"15","author":"Abdel-Rahman","year":"2019","journal-title":"Future Oncol"},{"key":"10.1016\/j.radonc.2020.08.019_b0025","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1002\/cncr.21907","article-title":"Generalizability of cancer clinical trial results: prognostic differences between participants and nonparticipants","volume":"106","author":"Elting","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2020.08.019_b0030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/eb-2017-102701","article-title":"The limitations of using randomised controlled trials as a basis for developing treatment guidelines","volume":"21","author":"Mulder","year":"2018","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.radonc.2020.08.019_b0035","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h2147","article-title":"The PRECIS-2 tool: designing trials that are fit for purpose","volume":"350","author":"Loudon","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.radonc.2020.08.019_b0040","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s40880-017-0257-9","article-title":"Nasopharyngeal carcinoma incidence and mortality in China, 2013","volume":"36","author":"Wei","year":"2017","journal-title":"Chin J Cancer"},{"key":"10.1016\/j.radonc.2020.08.019_b0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1470-2045(11)70320-5","article-title":"Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase III multicentre randomised controlled trial","volume":"13","author":"Chen","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2020.08.019_b0050","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S1470-2045(16)30410-7","article-title":"Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase III, multicentre, randomised controlled trial","volume":"17","author":"Sun","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2020.08.019_b0055","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMoa1905287","article-title":"Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma","volume":"381","author":"Zhang","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2020.08.019_b0060","unstructured":"Pfister DG, Spencer S, Adelstein D, Adkins D, Brizel DM, Burtness B, et al. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae): Head and Neck Cancers. Version 1.2019. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/head-and-neck.pdf. Accessed April 10, 2020."},{"key":"10.1016\/j.radonc.2020.08.019_b0065","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1158\/1078-0432.CCR-17-2656","article-title":"Induction chemotherapy plus concurrent chemoradiotherapy in endemic nasopharyngeal carcinoma: individual patient data pooled analysis of four randomized trials","volume":"24","author":"Chen","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2020.08.019_b0070","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1002\/cncr.30775","article-title":"Hepatitis B virus screening and reactivation and management of patients with nasopharyngeal carcinoma: A large-scale, big-data intelligence platform-based analysis from an endemic area","volume":"123","author":"Lv","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2020.08.019_b0075","article-title":"Real world evidence: experience and lessons from China","volume":"360","author":"Sun","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.radonc.2020.08.019_b0080","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejca.2017.01.002","article-title":"Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase III multicentre randomised controlled trial","volume":"75","author":"Chen","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2020.08.019_b0085","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ijc.32099","article-title":"Concurrent chemoradiotherapy with\/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long-term results of phase III randomized controlled trial","volume":"145","author":"Li","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.radonc.2020.08.019_b0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/cncr.31741","article-title":"Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma","volume":"125","author":"Guo","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2020.08.019_b0095","unstructured":"Common terminology criteria for adverse events ver.4.0. http:\/\/www.eortc.be\/services\/doc\/ctc\/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf. Accessed April 10, 2020."},{"key":"10.1016\/j.radonc.2020.08.019_b0100","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.radonc.2020.08.019_b0105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"10.1016\/j.radonc.2020.08.019_b0110","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jclinepi.2005.07.004","article-title":"A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods","volume":"59","author":"Sturmer","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.radonc.2020.08.019_b0115","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/096228029200100106","article-title":"Correspondence analysis in medical research","volume":"1","author":"Greenacre","year":"1992","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.radonc.2020.08.019_b0120","first-page":"1337","article-title":"Who is the marginal patient? Understanding instrumental variables estimates of treatment effects","volume":"33","author":"Harris","year":"1998","journal-title":"Health Serv Res"},{"key":"10.1016\/j.radonc.2020.08.019_b0125","article-title":"Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014\u201316: cross sectional analysis","volume":"366","author":"Naci","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.radonc.2020.08.019_b0130","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0022-3476(99)70400-2","article-title":"The \u201cinclusion benefit\u201d in clinical trials","volume":"134","author":"Lantos","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.radonc.2020.08.019_b0135","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13063-017-1870-2","article-title":"Why clinical trial outcomes fail to translate into benefits for patients","volume":"18","author":"Heneghan","year":"2017","journal-title":"Trials"},{"key":"10.1016\/j.radonc.2020.08.019_b0140","article-title":"A comparison between the sixth and seventh editions of the UICC\/AJCC staging system for nasopharyngeal carcinoma in a Chinese cohort","volume":"9","author":"Li","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.radonc.2020.08.019_b0145","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1001\/jama.291.22.2720","article-title":"Participation in cancer clinical trials: race-, sex-, and age-based disparities","volume":"291","author":"Murthy","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.radonc.2020.08.019_b0150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.7326\/0003-4819-155-1-201107050-00006","article-title":"Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study","volume":"155","author":"Dechartres","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.radonc.2020.08.019_b0155","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/jamaoncol.2018.5953","article-title":"Association of patient comorbid conditions with cancer clinical trial participation","volume":"5","author":"Unger","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2020.08.019_b0160","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cct.2009.09.003","article-title":"Disappointment and drop-out rate after being allocated to control group in a smoking cessation trial","volume":"31","author":"Lindstrom","year":"2010","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.radonc.2020.08.019_b0165","article-title":"Understanding the Hawthorne effect","volume":"351","author":"Sedgwick","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.radonc.2020.08.019_b0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1179\/106698111X12899036752014","article-title":"Clinical equipoise and personal equipoise: two necessary ingredients for reducing bias in manual therapy trials","volume":"19","author":"Cook","year":"2011","journal-title":"J Man Manip Ther"},{"key":"10.1016\/j.radonc.2020.08.019_b0175","article-title":"Is the concept of clinical equipoise still relevant to research?","volume":"359","author":"Hey","year":"2017","journal-title":"BMJ"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814020307374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814020307374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:13:53Z","timestamp":1759122833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814020307374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":35,"alternative-id":["S0167814020307374"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2020.08.019","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between outcome disparities and pragmatic features related to clinical trial and real-world settings in nasopharyngeal carcinoma: A population-based retrospective cohort study, 2006\u20132016","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2020.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}